Lowey Dannenberg probes ADMA Biologics after 2025 growth allegations

The law firm said it is investigating potential federal securities law violations after a Culper Research report alleged channel stuffing and said ADMA’s real 2025 growth was negative 3% rather than the reported 20%.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.